AI vs. standard tool: which catches more drug dangers in the ICU?
NCT ID NCT07314125
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether ChatGPT-5 can detect harmful drug interactions in intensive care patients better than a standard computer system. Researchers analyzed medication lists from 101 ICU patients and compared the AI's findings to the usual tool. The goal is to see if AI can improve safety for critically ill patients on multiple medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTIFICAL INTELLIGENCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bursa Yuksek Ihtisas Research and Education Hospital
Bursa, Bursa, 16235, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads gender from the jaw: a new tool for forensic identification?
- AI vs professors: who grades better in physiotherapy?
- AI vs. doctors: who reads brain data better in spine surgery?
- Phone AI could spot eye disease in remote areas
- AI wearable could spot Parkinson's freezing episodes at home
- AI app aims to get oral cancer patients back to work